13.2 C
New York
Friday, May 20, 2022

The UK listing does offer some CBD products but it means that a lot of the market has to be removed

- Advertisement -

The number of CBD products still in the process of obtaining full authorization in the UK has expanded after it was announced that the Food Standards Agency (FSA) had submitted 70 applications covering a total of 3,536 products.

Products on the list released on Thursday, and those previously offered by the FSA may remain for sale while products that fail to be included and any other non-compliant products on the market must now be withdrawn from consumer outlets, and may not be traded or sold in the UK.

“Being on the list means that the application is credible and that the FSA has, or soon expects to receive, important scientific evidence from the applicant from which to judge safety,” said Emily Miles, chief executive of the FSA..

‘No guarantee’

“I want to stress that the FSA does not endorse publicly-listed products, and their listing does not guarantee that they will be authorized as they have not been fully evaluated for their safety,” said Miles.

“But we have taken the step of publishing the list so that local authorities, retailers and consumers can make informed judgments about what they stock and buy, as we gradually bring this growing market into compliance with the law,” Miles added.

The newly listed products join products that previously reached stage 1 of the UK’s three-stage food safety licensing process. The new 70 applications cover multiple products under the same product or brand, and include those from two major European Unions.

The FSA list covers products sold in England and Wales. As a member state of the European Union, Ireland operates under the EU food safety rules; Northern Ireland is also subject to EU regulations as a result of the Brexit protocols.

eagerly awaited list

Producers eagerly anticipated the FSA’s announcements as it licked its chops at the UK plum market for consumer CBD products, estimated It could be worth 690 million pounds (~814.5 million euros; ~$905.7 million) in 2021, according to the Association of the Cannabis Industry (ACI), which worked with the FSA in crafting the CBD system under new UK food rules.

The ACI has urged companies that sell CBD products immediately – including supermarkets, convenience stores, health food stores, pharmacies, online retailers, cafes and restaurants – to check their current stock against the FSA list to ensure they comply with the UK’s Trade Standards Authority.

Sixty-five of the 70 newly approved applications, carrying 3,479 products, are now in the pre-validation (or “pending evidence”) stage. The remaining five applications, which carry 57 products, have reached the verification (or “risk assessment”) stage, the second stage, and are awaiting the FSA’s decision on the full authorization, the final stage.

“In some cases, the clock may need to be stopped during this next phase, and that could result in a slight delay” if additional evidence such as toxicology and other documentation is needed, said Ruth Willis of the FSA’s New Foods team. The ACI estimated that this process would take up to seven months.

680 applications rejected

The ACI said the 70 approved applications listed Thursday bring the total number of “live” files in the FSA process to 182, of which 175 are currently in the pre-validation stage and seven are in the verification stage.

Of the total 900 new food applications submitted to the FSA by CBD producers since January 1, 2021, more than 680 have now been rejected while another 42 have been voluntarily withdrawn by applicants, according to the ACI.

There is no way to predict how many products that remain active in the FSA process can reach full authorization, the ACI said in a conference call.

ACI’s Steve Moore said the publication of the latest list “demonstrates the progress the sector has made in meeting compliance requirements and creates greater regulatory certainty, which in turn will increase consumer confidence levels, encourage investment in the sector, and foster innovation.” Founder and strategic advisor.

Unified apps

The association said that of the 70 applicants who submitted the list, 46 came through a consortium initiated by ACI. All of its products are approved, although the list does not refer to products listed under the ACI.

EIHA Projects GmbH, a similar consortium organized by the European Industrial Hemp Association, has provided multiple applications covering CBD isolates and full spectrum extract products. This consortium apparently has rejected some products, noting in a press release that it has noted “some inaccuracies, inconsistencies, and indeed some surprising omissions on this list.” The EIHA consortium said it would “review these matters over the coming days and continue our open discussions with the FSA.”

Meanwhile, the ACI said it has finished the live phase of studying toxicology under OECD guidelines, which is required to validate food safety files; The data analysis is expected to be completed in June. The EIHA consortium said it is also in the midst of toxicology studies to support its applications.

From 2019 to 2021, sales of CBD doubled in the UK, making the non-EU country the second largest consumer market in the world after the USA, and the first jurisdiction globally to set specific rules for cannabis extracts.

*************
Are you looking for medical marijuana growing guides and books about cannabis? Then you should not miss our online bookstore with hundreds of books about marijuana.
********
Grow guide for marijuana beginners.
- Advertisement -THC University

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Connected

420FansLike
2,306FollowersFollow
420SubscribersSubscribe
- Advertisement -

Latest Articles